Related references
Note: Only part of the references are listed.Kruppel-Like Factor 8 Overexpression Correlates with Poor Prognosis in Non-Small Cell Lung Cancer
Jianchao Li et al.
PATHOLOGY & ONCOLOGY RESEARCH (2019)
Six2 promotes non-small cell lung cancer cell stemness via transcriptionally and epigenetically regulating E-cadherin
Huaying Hou et al.
CELL PROLIFERATION (2019)
Homeobox C8 is a transcriptional repressor of E-cadherin gene expression in non-small cell lung cancer
Jie Zhang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2019)
Prognostic value of Twist, Snail and E-cadherin expression in pathological NO non-small-cell lung cancer: a retrospective cohort study
Guanghui Wang et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2018)
High expression of P-cadherin is significantly associated with poor prognosis in patients with non-small-cell lung cancer
Sachiko Imai et al.
LUNG CANCER (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Expressions of KAI1 and E-cadherin in nonsmall cell lung cancer and their correlation with vasculogenic mimicry
Hongfei Ci et al.
MEDICINE (2018)
Long-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is 'cured' from postoperative recurrence?
Keigo Sekihara et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2017)
Overexpression of PAK1 Correlates with Aberrant Expression of EMT Markers and Poor Prognosis in Non-Small Cell Lung Cancer
Zhiying Yang et al.
JOURNAL OF CANCER (2017)
LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC)
Rong He et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Restraining FOXO3-dependent transcriptional BMF activation underpins tumour growth and metastasis of E-cadherin-negative breast cancer
M. Hornsveld et al.
CELL DEATH AND DIFFERENTIATION (2016)
Rac1 overexpression is correlated with epithelial mesenchymal transition and predicts poor prognosis in non-small cell lung cancer
Yujuan Zhou et al.
JOURNAL OF CANCER (2016)
Prognostic value and clinicopathological significance of epithelial cadherin expression in non-small cell lung cancer
Zhi-Xin Qiu et al.
THORACIC CANCER (2015)
Positive expression of pro-opiomelanocortin (POMC) is a novel independent poor prognostic marker in surgically resected non-small cell lung cancer
Ligang Hao et al.
TUMOR BIOLOGY (2015)
Serum starvation regulates E-cadherin upregulation via activation of c-Src in non-small-cell lung cancer A549 cells
Su Dong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)
MCAM expression is associated with poor prognosis in non-small cell lung cancer
X. Zhang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2014)
Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
Mark G. Kris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Prognostic and Clinicopathological Significance of Downregulated E-Cadherin Expression in Patients with Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis
Yan-Long Yang et al.
PLOS ONE (2014)
Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma
Hua Zhang et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Alteration of the E-Cadherin/β-Catenin Complex Is an Independent Poor Prognostic Factor in Lung Adenocarcinoma
Hyojin Kim et al.
KOREAN JOURNAL OF PATHOLOGY (2013)
The impact of E-cadherin expression on non-small cell lung cancer survival: a meta-analysis
Ying Wu et al.
MOLECULAR BIOLOGY REPORTS (2012)
FoxQ1 Overexpression Influences Poor Prognosis in Non-Small Cell Lung Cancer, Associates with the Phenomenon of EMT
Jian Feng et al.
PLOS ONE (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Effect of Brain- and Tumor-Derived Connective Tissue Growth Factor on Glioma Invasion
Lincoln A. Edwards et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Expression of integrin-linked kinase in lung squamous cell carcinoma and adenocarcinoma: correlation with E-cadherin expression, tumor microvessel density and clinical outcome
Juanhan Yu et al.
VIRCHOWS ARCHIV (2011)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Prognostic Impact of Vascular Endothelial Growth Factor-A and E-Cadherin Expression in Completely Resected Pathologic Stage I Non-Small Cell Lung Cancer
Qiang Lin et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
Deregulation of p27 and Cyclin D1/D3 Control Over Mitosis Is Associated with Unfavorable Prognosis in Non-small Cell Lung Cancer, as Determined in 405 Operated Patients
William Sterlacci et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Association between lymphangiogenesis-/micrometastasis- and adhesion-related molecules in resected stage I NSCLC
Toshihiro Yamashita et al.
LUNG CANCER (2010)
Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients
M. I. Galleges Ruiz et al.
BRITISH JOURNAL OF CANCER (2009)
Three Immunomarker Support Vector Machines-Based Prognostic Classifiers for Stage IB Non-Small-Cell Lung Cancer
Zhi-Hua Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The prognostic impact of NF-κB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer
S. Al-Saad et al.
BRITISH JOURNAL OF CANCER (2008)
Risk of Recurrence in Surgically Resected Stage I Adenocarcinoma of the Lung: Histopathologic and Immunohistochemical Analysis
Sukki Cho et al.
LUNG (2008)
Prognostic significance of dysadherin expression in patients with non-small cell lung cancer
M Tamura et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2005)
Clinical application of biological markers for treatments of resectable non-small-cell lung cancers
C Huang et al.
BRITISH JOURNAL OF CANCER (2005)
Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry
G Deeb et al.
MODERN PATHOLOGY (2004)
E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer
DG Liu et al.
ANNALS OF THORACIC SURGERY (2001)
E-cadherin expression in surgically-resected non-small cell lung cancers - A clinicopathological study
YC Lee et al.
THORACIC AND CARDIOVASCULAR SURGEON (2000)
Share Paper
